Granite Group Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$391K Buy
326
+5
+2% +$5.11K 0.23% 57
2026
Q1
$299K Buy
321
+22
+7% +$22.3K 0.18% 67
2025
Q4
$321K Sell
299
-3
-1% -$2.87K 0.18% 63
2025
Q3
$230K Buy
302
+3
+1% +$2.23K 0.14% 73
2025
Q2
$233K Sell
299
-90
-23% -$69.9K 0.14% 71
2025
Q1
$321K Hold
389
0.22% 51
2024
Q4
$300K Hold
389
0.19% 53
2024
Q3
$345K Hold
389
0.22% 48
2024
Q2
$352K Sell
389
-398
-51% -$318K 0.27% 50
2024
Q1
$612K Hold
787
0.41% 37
2023
Q4
$578K Buy
+787
New +$459K 0.41% 40

Other funds holding LLY

Granite Group Advisors's LLY Position: Q2 2026 in Review

Granite Group Advisors increased its Eli Lilly (LLY) stake by 1.6% in Q2 2026, buying an estimated $5.11K and bringing the position to 326 shares worth $391K. The position accounts for 0.23% of the portfolio, ranked #57.

Granite Group Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $612K in Q1 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Granite Group Advisors held 326 shares of Eli Lilly worth $391K as of Q2 2026.
  • Granite Group Advisors bought 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.23% of Granite Group Advisors's portfolio in Q2 2026, its #57 holding.
  • Granite Group Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Granite Group Advisors's Eli Lilly position peaked at $612K in Q1 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Granite Group Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.